Evidence map›Paper›PMID 32383215›Full record

ReviewAdvanced materials (Deerfield Beach, Fla.)2020

Phase-Change Materials for Controlled Release and Related Applications.

Jichuan Qiu, Da Huo, Younan Xia

Abstract readReview
In one paragraph

Review in Advanced materials (Deerfield Beach, Fla.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Supramolecular Phase Change Materials for Spatiotemporally Thermal Energy Utilization.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Putting Hybrid Nanomaterials to Work for Biomedical Applications.Angewandte Chemie (International ed. in English) · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jichuan QiuThe Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, 30332, USA.ORCID https://orcid.org/0000-0002-9993-8220
Da HuoThe Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, 30332, USA.ORCID https://orcid.org/0000-0002-6530-0632
Younan XiaThe Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, 30332, USA.ORCID https://orcid.org/0000-0003-2431-7048

Funding

NIH Director's Pioneer AwardDP1OD000798 · OD · WASHINGTON UNIVERSITY · PI XIA, YOUNAN · 2006 to 2010
$3.8M
GOLD NANOCAGES AS A NEW CLASS OF THERAPEUTIC AGENTS FOR PHOTOTHERMAL CANCER TREATR01CA138527 · NCI · WASHINGTON UNIVERSITY · PI XIA, YOUNAN · 2010 to 2014
$1.9M
Nanofiber Conduits with a Honeycomb Structure for Repairing Large Defects in Thick NervesR01EB020050 · NIBIB · GEORGIA INSTITUTE OF TECHNOLOGY · PI BOULIS, NICHOLAS M, XIA, YOUNAN · 2015 to 2018
$1.7M
Georgia Institute of TechnologyNCI NIH HHS R01 CA138527NIBIB NIH HHS R01 EB020050NIH HHS DP1 OD000798NIH HHS R01 CA138527NIH HHS R01 EB020050
6 · The paper itself

Abstract

Phase-change materials (PCMs) have emerged as a novel class of thermo-responsive materials for controlled release, where the payloads encapsulated in a solid matrix are released only upon melting the PCM to trigger a solid-to-liquid phase transition. Herein, the advances over the past 10 years in utilizing PCMs as a versatile platform for the encapsulation and release of various types of therapeutic agents and biological effectors are highlighted. A brief introduction to PCMs in the context of desired properties for controlled release and related applications is provided. Among the various types of PCMs, a specific focus is placed on fatty acids and fatty alcohols for their natural availability, low toxicity, biodegradability, diversity, high abundance, and low cost. Then, various methods capable of processing PCMs, and their mixtures with payloads, into stable suspensions of colloidal particles, and the different means for triggering the solid-to-liquid phase transition are discussed. Finally, a range of applications enabled by the controlled release system based on PCMs are presented together with some perspectives on future directions.

Indexed as

ColloidsDelayed-Action PreparationsFatty AcidsFatty AlcoholsInfrared RaysIntercellular Signaling Peptides and ProteinsNanoparticlesPhase TransitionPhospholipidsUltrasonic WavesColloidsDelayed-Action PreparationsFatty AcidsFatty AlcoholsIntercellular Signaling Peptides and ProteinsPhospholipidscontrolled releasefatty acidsphase-change materialsstimuli-responsive drug delivery

Identifiers

PMID32383215
PMCPMC7473464

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.